Home > Qtrly Results > ERIS LIFESCIENCES

ERIS LIFESCIENCES
Quarterly Results Analysis [Mar2026]

ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ERIS LIFESCIENCES
Please provide your vote to see the results

ERIS LIFESCIENCES Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
Audited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
Audited
Revenues ₹757 Cr ₹807 Cr ₹792 Cr ₹773 Cr ₹705 Cr ₹727 Cr ₹741 Cr ₹720 Cr
Expenses ₹483 Cr ₹526 Cr ₹504 Cr ₹496 Cr ₹453 Cr ₹477 Cr ₹477 Cr ₹470 Cr
Operating Income ₹274 Cr ₹282 Cr ₹288 Cr ₹277 Cr ₹252 Cr ₹250 Cr ₹265 Cr ₹250 Cr
Other Income ₹2 Cr ₹0 Cr ₹3 Cr ₹3 Cr ₹8 Cr ₹4 Cr ₹5 Cr ₹2 Cr
Interest ₹46 Cr ₹49 Cr ₹50 Cr ₹49 Cr ₹54 Cr ₹57 Cr ₹59 Cr ₹60 Cr
Depreciation ₹70 Cr ₹70 Cr ₹69 Cr ₹71 Cr ₹77 Cr ₹81 Cr ₹80 Cr ₹76 Cr
Profit Before Tax ₹161 Cr ₹145 Cr ₹172 Cr ₹160 Cr ₹129 Cr ₹116 Cr ₹129 Cr ₹116 Cr
Profit After Tax ₹280 Cr ₹109 Cr ₹134 Cr ₹124 Cr ₹102 Cr ₹87 Cr ₹96 Cr ₹90 Cr
EPS ₹20.33 ₹7.32 ₹8.82 ₹8.66 ₹6.89 ₹6.15 ₹6.73 ₹6.12
Industry Peers & Returns1W1M1Y
ERIS LIFESCIENCES -2.5% -0.8% -10.4%
SUN PHARMACEUTICAL INDUSTRIES -2.4% 6.4% 7%
DIVIS LABORATORIES -0.9% 5% 3.3%
TORRENT PHARMACEUTICALS 1.6% 7.6% 38.5%
CIPLA 1.2% 7.7% -3.4%
DR REDDYS LABORATORIES 0.1% -1.2% 8.7%
MANKIND PHARMA -3.7% 6.8% -0.8%
LUPIN -0.4% -2% 15%
ZYDUS LIFESCIENCES 4.8% 16.5% 19.4%

ERIS LIFESCIENCES Quarterly Revenues

Revenues
Q-o-Q

-6.30 %

Y-o-Y

7.27 %

Quarters Revenues % Change
Mar2026 ₹757 Cr
-6.30
Dec2025 ₹807 Cr
1.90
Sep2025 ₹792 Cr
2.51
Jun2025 ₹773 Cr
9.60
Mar2025 ₹705 Cr
-3.04
Dec2024 ₹727 Cr
-1.85
Sep2024 ₹741 Cr
2.98
Jun2024 ₹720 Cr -

ERIS LIFESCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

-2.86 %

Y-o-Y

8.39 %

Quarters Operating Profit % Change
Mar2026 ₹274 Cr
-2.86
Dec2025 ₹282 Cr
-2.29
Sep2025 ₹288 Cr
4.16
Jun2025 ₹277 Cr
9.64
Mar2025 ₹252 Cr
0.83
Dec2024 ₹250 Cr
-5.37
Sep2024 ₹265 Cr
5.81
Jun2024 ₹250 Cr -
Operating Margins
Q-o-Q

3.67 %

Y-o-Y

1.06 %

Quarters Operating Margin% % Change
Mar2026 36.16%
3.67
Dec2025 34.88%
-4.10
Sep2025 36.37%
1.59
Jun2025 35.8%
0.06
Mar2025 35.78%
3.98
Dec2024 34.41%
-3.59
Sep2024 35.69%
2.76
Jun2024 34.73% -

ERIS LIFESCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

157.84 %

Y-o-Y

174.02 %

Quarters Profit After Tax % Change
Mar2026 ₹280 Cr
157.84
Dec2025 ₹109 Cr
-18.99
Sep2025 ₹134 Cr
8.03
Jun2025 ₹124 Cr
21.43
Mar2025 ₹102 Cr
17.49
Dec2024 ₹87 Cr
-9.70
Sep2024 ₹96 Cr
7.66
Jun2024 ₹90 Cr -
PAT Margins
Q-o-Q

175.26 %

Y-o-Y

155.52 %

Quarters PAT Margin(%) % Change
Mar2026 37.05 %
175.26
Dec2025 13.46 %
-20.50
Sep2025 16.93 %
5.35
Jun2025 16.07 %
10.83
Mar2025 14.5 %
21.14
Dec2024 11.97 %
-7.99
Sep2024 13.01 %
4.58
Jun2024 12.44 % -

ERIS LIFESCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

177.73 %

Y-o-Y

195.07 %

Quarters EPS % Change
Mar2026 ₹20.33
177.73
Dec2025 ₹7.32
-17.01
Sep2025 ₹8.82
1.85
Jun2025 ₹8.66
25.69
Mar2025 ₹6.89
12.03
Dec2024 ₹6.15
-8.62
Sep2024 ₹6.73
9.97
Jun2024 ₹6.12 -

You may also like the below Video Courses